KAMI PERRY: Open Payments
NPI 1053183376 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 12 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 6 | $144 |
| GENZYME CORPORATION | 2 | $45 |
| Madrigal Pharmaceuticals | 1 | $36 |
| Phathom Pharmaceuticals, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $22 |
| Amgen Inc. | 1 | $21 |
Products named: IBSRELA, DUPIXENT, REZDIFFRA, VOQUEZNA, Wegovy, UPLIZNA.
Industry payments across AL — which companies pay providers there.
